{"name":"Coya Therapeutics","slug":"coya-therapeutics","ticker":"","exchange":"","domain":"coya.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxOcmdxMjBkd1BMQUpHbW9NZkJIb2xFODRZTGpHdHBUNWltYUJ5cUxtVU1uLTBVb1VpcGZYUV9pWjAtWklGQ0VkSXdGV2RxbUdIaERiSGJseElhbzZMcVZKYzF2aFBaUjZVQUQ2YTdkZWFKUEZtVWQ3ZWZFRTBleTYybVVDVG5pNWxQVmF3bFFuUXNNWXBhSXh1aVhnWnNCU1RxMW9DWFAwaFVJcjE4dGlrRF9UMHZUcm5hWXFjNGNOd21FWnowcHk2N2ctcW5qbzgtRElhVkVSMzRLa25wd0ZXekFR?oc=5","date":"2026-04-03","type":"pipeline","source":"The Globe and Mail","summary":"Coya Therapeutics Announces Leadership Changes and New Director - The Globe and Mail","headline":"Coya Therapeutics Announces Leadership Changes and New Director","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxOVFVhREZFejhZZG95dmVtV1ZrcmFiLTlOTlh4T2xkUk5JaTNHYzNQUE5Mal9icHRqc1pnbW5XbVlmc0Rac3JUSTE0S1NXUnV0X2hVS3NQeE9DX0h5cjQyQ0tieE5zb25FUWJSZlR1Y1ZVQVZ0Q01WenRmdnZXWlhiQmVMUGZ3c2tGaERGZ1p1SVgtRkNkQ0tOc1NFYkpFYkFvcFJzV1NRQXdaLTZlLUVrWWhBdU44Y2JZZjk1TXk4LUo2a251YmpLeFFFXzVIQWJEN3NGQTFsaEVhY0pvSmtXNktZXzdvT1lSM3lpcWxCMjF5RmxxamZHb0tn?oc=5","date":"2026-04-02","type":"pipeline","source":"Business Wire","summary":"Coya Therapeutics Announces Planned Board Transition and Appointment of Mark H. Pavao as Independent Director - Business Wire","headline":"Coya Therapeutics Announces Planned Board Transition and Appointment of Mark H. Pavao as Independent Director","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxNSmpXQmZkMUZEOFVJQXVZbTlnVXVIX2hGZzRSb0NjNURvN3lySm5jaGhBWGJXemxQZW1TNVRnMm9oVl9UQWFLSXM1cmhmdDZINWxDMW9DVTJ2dzBpMWM5aUxxMHpXR3B2UnRRVG03ZDAxaU5Tb0l4b3hKcXRsVFFIeC0zbkZaM1Rib1FPa0tGNTJ1MnF2Z3pkWjJCNnZBZTRNU010VGxZM2FER0Q5TnhvQ3JnUklaOEVNbFZrQklzV3BNeDBhMUMxNTdNLV9OSlpGUzBILTZxR3hWM2ZVS0Y0cV9XTkw0bllIVW9KZDd1dVVwcnJiNnRxYWNmbUd2WHB2S0pv?oc=5","date":"2026-03-17","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Are Bullish on These Healthcare Stocks: Ascendis Pharma (ASND), Plus Therapeutics (PSTV) - The Globe and Mail","headline":"Analysts Are Bullish on These Healthcare Stocks: Ascendis Pharma (ASND), Plus Therapeutics (PSTV)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE10dVNFRnB0dmE1MnpmZDNYSnB2blJ3MWJpT25SZkhJZDBWb0g5VWFKY01nYmlFSE1FRm5tb2lOM01rQWlROWpfR3ZZaHRUci1uclBIa19oODVGaFlpSmpJU1Vn?oc=5","date":"2026-02-17","type":"pipeline","source":"Labiotech.eu","summary":"Can Treg cell therapy really target autoimmunity? - Labiotech.eu","headline":"Can Treg cell therapy really target autoimmunity?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPb1dLUmxDWkhVTW5hLV9UNDFyRGJaQWtRYTNmUk1NY1g4cW85NDlLalhWRUhCakdNXzR5NjgyRlkycG5ybzBDUXhXa21vTHNzcTlVTFVRRUcwazZpa2pBaFV2YTJnRDd5aVNzaG4yMEJoMFozZmVxeXdrV1AyVURhdGVhSDBYdw?oc=5","date":"2026-02-10","type":"pipeline","source":"InnovationMap","summary":"Houston biotech co. raises $11M to advance ALS drug development - InnovationMap","headline":"Houston biotech co. raises $11M to advance ALS drug development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOcnlRODMxcDc2LUV5NG1hdzNOSnVLMXJnd3psdlZRcUdKUWdhZ01kakMySVVzRmsySVM0MTNVYktyN055S2hmd1RyRzlXVDBPNHlYS21UYWtsT2JxdmgtZ01uU2R3UGtLQndvSGwzTUQ5ekhXbThSQW5MZnRWOUJ5dnVrX3B4RU9BTV8tWFpfbzVhY3hxMzg1eE42WkVRak1waGwzRUV1bHdUUkdjNTI2dEVNUHoxcmJX?oc=5","date":"2025-11-05","type":"pipeline","source":"Drug Target Review","summary":"IL-2 and GLP-1 receptor agonist combination tackles neuroinflammation - Drug Target Review","headline":"IL-2 and GLP-1 receptor agonist combination tackles neuroinflammation","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-16","type":"pipeline","source":"simplywall.st","summary":"Is Coya Therapeutics (NASDAQ:COYA) In A Good Position To Invest In Growth? - simplywall.st","headline":"Is Coya Therapeutics (NASDAQ:COYA) In A Good Position To Invest In Growth?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNWlJ6Q3BXcXZJYUlzMkdhOHhLMUdOY1R0U3hDUE9BZWlRZDYzZEJNZE1Tbm51U0xySnJ6Y3V6c3YwWjVqMXpib0JuNDNpajF6WUZ5RW1KOVhTZkg0eDJXQUR6cEh1aFExcjBOVGQzbk9Hb1JEbkh4NkI2LVQzYjdFS2N2WHZDa2d5X21BSjFkNElMeUxiYTFMSHNLSmYyM3FWT2c?oc=5","date":"2025-08-28","type":"regulatory","source":"PharmaTimes","summary":"Coya Therapeutics to progress trial of ALS treatment upon FDA approval - PharmaTimes","headline":"Coya Therapeutics to progress trial of ALS treatment upon FDA approval","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQRjRJVDVsamh2c3hyazN1bkktTDVxVWRja2dZN3dZTjBtOHZjMzVnT2I1em1BRzBQa2hnaGkwOS1xUTMwYXJoVVVSc1RRQThrX3NaQ1IwaUVkTlBJRXU3RExSX3F3UGY5d3RJRXVjOE8tdGxVQUstWFdLd05MSTdjSFhqMS1rR29KblZndUYwSGIxU0tsSWw1ekhxWmpqS28?oc=5","date":"2025-07-30","type":"regulatory","source":"Fierce Biotech","summary":"FDA misses IND deadline for Coya's ALS asset, cites lack of resources - Fierce Biotech","headline":"FDA misses IND deadline for Coya's ALS asset, cites lack of resources","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE1NMUhva2Z3anY2OEZVM1RKd3BXaWdOVUVtSjNKeVlZV3YwR2JweXlOQVRscVU4YzV6ODQ1Si1GYnNVRFR6SUNiS1l3VGNVdkxJWl90ZDFmZmJZLVNoSE1HdGdLNk9UWC1YZm5XZ2pkQTE2cFNCZ2NaRmxQLVo?oc=5","date":"2025-06-25","type":"pipeline","source":"Pharma Voice","summary":"After myriad failures, a new wave of ALS drugs approaches - Pharma Voice","headline":"After myriad failures, a new wave of ALS drugs approaches","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxOY1diMWQxZGRFMjhxdWlqNHRxZmNWVVM3em5lRzV4NmtITmp2VUR2N2xUeHlsWE1NYmlEQkc1T0loNTROMHI0RmpILXlhTXFtT0tkeURKOW8yUXQtejQtZElDMnBkQlNIR0dTcjU2ZVM5cnNYNXk5RGxwdnNESEw3WDVVc3pSdw?oc=5","date":"2025-01-27","type":"pipeline","source":"Pharma Voice","summary":"An ALS treatment wave is approaching, and this biotech CEO is ready to surf - Pharma Voice","headline":"An ALS treatment wave is approaching, and this biotech CEO is ready to surf","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxNOXo5enhvdlBSbkozUTI1eTg4N1l6WGxMZFE3MENuUlBWeHlZcXMtWnIxRVFMN1FBd0JoeFBmSTJjeDdEeno4ZmV1Ri1CQ241Rl9UUjFIczl0OWlCSDVWTTdYd2NIY3J4WWR5ODRxMmVIamR2U0IwdXBhT05vQzVxQlF0SVpkTy1wcUZXQ19sVThibVlwcHVsNDVjTzJRaXpROFZrbWJibWtoMTB3UEM3cS1uejl4cEdMYVhpUEpybV9PdWpuUkVOZkJScTM3SW94STM3QmxOMHlXbUZGaFdoR2ZpZG0?oc=5","date":"2024-10-29","type":"trial","source":"reuters.com","summary":"Coya Therapeutics reports positive immune response, safety in mid-stage Alzheimer's drug trial - reuters.com","headline":"Coya Therapeutics reports positive immune response, safety in mid-stage Alzheimer's drug trial","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}